Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Improvement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T PTPN22 Variant for Immunotherapy in Endocrine Autoimmunity

Frontiers in Immunology(2022)10.3389/fimmu.2022.838331Source: DataRank Database

Improvement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T PTPN22 Variant for Immunotherapy in Endocrine Autoimmunity is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0.385. It has been cited 12 times.

N/A

0.385DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.94)OA: goldTopics (47)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.385

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (13)

Eugenia Belcastro ORCID,Francesca Ceccacci ORCID,Stefania Petrini ORCID,Libenzio Adrian Conti ORCID,Olivia Pagliarosi ORCID

Live enrichment

PubMed:35355982 PMC:PMC8959661 OpenAlex:https://openalex.org/W4220957988

Ministero della Salute

Grant: RF-2019-1236988

National Institutes of Health

Grant: AI132790

NIAID NIH HHS

Grant: R01 AI132790

Ministero della Salute

FWCI

0.94

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://doi.org/10.3389/fimmu.2022.838331

publisherhttps://doi.org/10.3389/fimmu.2022.838331

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.838331/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35355982

repositoryhttps://hdl.handle.net/11568/1181867

Fields of Study

Glycosylation and Glycoproteins ResearchDiabetes and associated disordersProtein Tyrosine PhosphatasesAutoimmunityDiabetes Mellitus, Type 1HumansImmunologic FactorsImmunotherapyLeukocytes, MononuclearN-Acetylneuraminic AcidPhosphoric Monoester HydrolasesProtein Tyrosine Phosphatase, Non-Receptor Type 22RNA, Small InterferingSialic Acid Binding Immunoglobulin-like Lectins

MeSH Terms

Diabetes Mellitus, Type 1HumansImmunologic FactorsImmunotherapyLeukocytes, MononuclearPhosphoric Monoester HydrolasesAutoimmunityN-Acetylneuraminic AcidRNA, Small InterferingProtein Tyrosine Phosphatase, Non-Receptor Type 22Sialic Acid Binding Immunoglobulin-like Lectins

Keywords

PTPN22AutoimmunityPeripheral blood mononuclear cellT-cell receptorBiologyProtein tyrosine phosphataseImmunotherapyImmunologyT cellMolecular biologyCancer researchChemistryCell biologyPhosphorylationImmune systemGeneBiochemistryIn vitroT1dVariant Ptpn22Functionalized LipoplexesPegylated Lipid F9

Sustainable Development Goals

SDG 0: Good health and well-being

Improvement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T PTPN22 Variant for Immunotherapy in Endocrine Autoimmunity

FAIR Checklist

DataRank Breakdown

Authors (13)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)